EXECUTIVE OVERVIEW Project Peri-Dry™ represents a proprietary, physics-driven biomedical device engineered to eliminate fecal incontinence and loose stool leakage across both ambulatory and high-acuity bedridden patient cohorts. Developed by a 32-year veteran Lead Colorectal and Urology Surgical Technologist, the device establishes a new clinical and consumer paradigm, bridging the gap between highly invasive indwelling hardware and passive, undignified containment systems like adult diapers.
THE MECHANISM OF ACTION & MATERIAL SCIENCE Unlike traditional diapers that merely catch waste after a leak occurs, Peri-Dry™ stops liquid and loose stool directly at the source. Deployed via a medical-grade, biodegradable safety applicator, the device utilizes a highly specialized 2–6 mL micro-absorbent core composed of a rayon/cotton blend wrapped cleanly in a non-woven polypropylene mesh layer. The device relies on immediate saturation by liquid waste and an accompanying hydrogel lubricant to form a soft, anatomically adaptive, vault-conforming rectal block. This advanced fluid-activated barrier completely prevents mucosal drying and tissue adherence. The system is securely anchored via a non-adherent internal seal at the anal opening, working in tandem with an external seal cinched flush against the anatomy by a proprietary 2mm soft, one-way cannulated stopper that completely prevents device migration. Wear-time is optimized for up to 6 hours, allowing full mucosal recovery during sleep cycles.
INTELLECTUAL PROPERTY & MANUFACTURING STATUS The asset portfolio is completely clean, corporate-held (Peri-Dry Medical, LLC), and fully protected by a granted global Utility Patent with 10 years of active lifecycle remaining, alongside supporting Design Patents and registered Trademarks. Production-ready manufacturing blueprints and engineering schematics have been fully finalized and short-run certified out of Griff Industries (Lancaster, CA) and Ames Rubber Manufacturing (Los Angeles, CA).
HUMAN FEASIBILITY & FEASIBILITY RUN DATA The underlying design physics have achieved complete proof of concept via a physician-guided human use feasibility run on 15 subjects spanning a complex pathological spectrum (including spinal cord injury, flaccid bowel, active Crohn's disease, and post-anorectal surgical failures). The data yielded a 100% success rate in zero-leakage compliance, 100% tissue tolerance with zero mucosal degradation, and exceptional compliance profiles for patient comfort, simple application, and total anatomical concealment.
STRATEGIC ALIGNMENT WITH PROCTER & GAMBLE The material architecture of Peri-Dry™ utilizes the exact core manufacturing competencies mastered by P&G’s automated, high-speed global production lines (Tampax and Pampers divisions). We are extending an exclusive first-look opportunity to Procter & Gamble to acquire or exclusively license this portfolio to dominate the rapidly expanding retail adult incontinence sector.